Harmonizing signal detection and benefit-risk evaluation schedules with Orbit ensures a structured, repeatable process that enhances both efficiency and consistency across pharmacovigilance and regulatory teams.

By automating the scheduling of safety signal reviews, BRAT meetings, and benefit-risk assessments, Orbit eliminates manual tracking, reduces administrative burden, and ensures timely decision-making. This alignment not only streamlines regulatory compliance but also fosters cross-functional collaboration, ensuring that safety updates and risk assessments are systematically reviewed and communicated across the organization. With a unified approach, teams can proactively manage evolving risks while maintaining a clear, auditable record of benefit-risk decisions.